The lead author of the latest studyPatrick Gleason, Assistant Vice President, Health Outcomes at Prime Therapeuticssaid in an interview with Endpoint News that the real-world data underscore the need for health plans to ensure patients receive comprehensive care, such as case and disease management programs aimed at behavior modification
Our services support your health journey as we handle prior authorizations and accept all major insurance plans, alleviating administrative burdens and helping you focus on what truly matters: achieving your weight loss goals
H.ThalamuthuA.MizoguchiT.et al
Does previous experience with a GLP-1 medication change where someone starts
You may also see better glycemic control, and there are often fewer side effects
However, due to the small sample size, the study was underpowered to detect a statistically significant difference (170)